Akums Drugs and Pharmaceuticals informs about transcript of earnings call

19 Feb 2026 Evaluate
Pursuant to the Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) 2015, Akums Drugs and Pharmaceuticals has informed that it enclosed the transcript of earnings/analyst conference call held on Monday, February 16, 2026 at 12:00 PM (IST) on Un-audited financial results for Q3 of FY26. The said transcript be also available on the Company’s website https://www.akums.in/investors/investors-meet/.

The above information is a part of company’s filings submitted to BSE. 

Akums Drugs & Pharma Share Price

478.75 -7.85 (-1.61%)
20-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.45
Dr. Reddys Lab 1280.30
Cipla 1341.45
Zydus Lifesciences 901.00
Lupin 2219.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×